Business Context and Reporting Period
Universe Pharmaceuticals INC, a foreign private issuer based in Ji'an, Jiangxi, China, filed this Form 6-K for the month of March 2021. The filing reports on the completion of its initial public offering (IPO) and the full exercise of the underwriter's over-allotment option.
Key Financial Metrics
- Gross Proceeds: $28.75 million (including over-allotment shares, before underwriting discounts and expenses).
- Offering Price: $5.00 per ordinary share.
- Shares Issued in Over-allotment: 750,000 ordinary shares.
- Par Value: $0.003125 per share.
- Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide a clear value for these operational metrics as the report focuses solely on the capital raise event.
Material Changes
The primary material change reported is the increase in capital raised through the full exercise of the over-allotment option by Univest Securities, LLC. The closing for the sale of these additional shares occurred on March 31, 2021.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, or specific operational risks. It includes a standard legal disclaimer stating that the report does not constitute an offer to sell securities in jurisdictions where such an offer would be unlawful without proper registration.
Investor Verification Checklist
- Verify the final net proceeds after deducting underwriting discounts and offering expenses.
- Confirm the total number of shares outstanding post-IPO and post-over-allotment.
- Review the attached press release (Exhibit 99.1) for additional details on the use of proceeds.
- Check subsequent filings for the company's operational financial performance, as this Form 6-K does not contain income statement or balance sheet data.